Evidence map›Paper›PMID 39200001›Full record

ArticleAntibiotics (Basel, Switzerland)2024

The pH-Insensitive Antimicrobial and Antibiofilm Activities of the Frog Skin Derived Peptide Esc(1-21): Promising Features for Novel Anti-Infective Drugs.

Maria Rosa Loffredo, Floriana Cappiello, Giacomo Cappella, Elisabetta Capuozzo, Luisa Torrini, Fabiana Diaco, Yuanpu Peter Di, Maria Luisa Mangoni, Bruno Casciaro

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Modulating Antimicrobial Activity and Structure of the Peptide Esc(1-21) via Site-Specific Isopeptide Bond Formation.Journal of peptide science : an official publication of the European Peptide Society · 2025
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maria Rosa LoffredoLaboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Biochemical Sciences, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0001-5040-5688
Floriana CappielloLaboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Biochemical Sciences, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0003-3423-8474
Giacomo CappellaLaboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Biochemical Sciences, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0009-0000-6180-166X
Elisabetta CapuozzoLaboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Biochemical Sciences, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0003-3132-6890
Luisa TorriniDepartment of Molecular Medicine, Sapienza University of Rome, 00185 Rome, Italy.
Fabiana DiacoDepartment of Molecular Medicine, Sapienza University of Rome, 00185 Rome, Italy.
Yuanpu Peter DiDepartment of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, PA 15261, USA.ORCID 0000-0003-2028-2087
Maria Luisa MangoniLaboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Biochemical Sciences, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-5991-5868
Bruno CasciaroLaboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Biochemical Sciences, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0003-1295-1084

Funding

Developing a novel class of peptide antibiotics targeting carbapenem-resistant Gram-negative organismsR01AI176537 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Yuanpu Peter Di · 2023 to 2026
$3.5M
Fondazione Italiana per la Ricerca sulla Fibrosi Cistica Project FFC#4/2022. Delegazione FFC Ricerca di Roma e della Franciacorta e Val CamonicaNextGeneration EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases Project no. PE00000007, INF-ACTNIAID NIH HHS R01 AI176537Sapienza University of Rome RM1221815DABA9B4Sapienza University of Rome RP122181619F624E
6 · The paper itself

Abstract

The number of antibiotic-resistant microbial infections is dramatically increasing, while the discovery of new antibiotics is significantly declining. Furthermore, the activity of antibiotics is negatively influenced by the ability of bacteria to form sessile communities, called biofilms, and by the microenvironment of the infection, characterized by an acidic pH, especially in the lungs of patients suffering from cystic fibrosis (CF). Antimicrobial peptides represent interesting alternatives to conventional antibiotics, and with expanding properties. Here, we explored the effects of an acidic pH on the antimicrobial and antibiofilm activities of the AMP Esc(1-21) and we found that it slightly lost activity (from 2- to 4-fold) against the planktonic form of a panel of Gram-negative bacteria, with respect to a ≥ 32-fold of traditional antibiotics. Furthermore, it retained its activity against the sessile form of these bacteria grown in media with a neutral pH, and showed similar or higher effectiveness against the biofilm form of bacteria grown in acidic media, simulating a CF-like acidic microenvironment, compared to physiological conditions.

Indexed as

acidic pHantibioticsantimicrobial peptidesbiofilmcystic fibrosisGram-negative bacteriainfections

Identifiers

PMID39200001
PMCPMC11350779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.